AB Science tiendra une conférence virtuelle sur les résultats du masitinib dans le cancer du pancréas le vendredi 11 décembre 2020

    NEXT STORY
    Immunicum AB (publ) Provides Additional Information on the Proposed Transaction and Virtual Investor Event Summary
    PREV STORY
    Novartis investigational STAMP inhibitor asciminib (ABL001) shows superior MMR rate to Bosulif®* in chronic myeloid leukemia trial
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Burning Rock Announces Pricing of Upsized Registered Secondary Public Offering of American Depositary Shares

    author_avatar
    NASDAQ Market News

    Dynavax to Present at J.P. Morgan 36th Annual Healthcare Conference

    BERKELEY, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ:DVAX) announced today ...

    author_avatar
    NASDAQ Market News

    Immatics Appoints Biotech Executive Eliot Forster to Board of Directors

    author_avatar
    NASDAQ Market News